PO-486 Surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimised EGF-based vaccination schedule
| Autor: | Mazorra, Z., Popa, X., Garcia, B., Huerta, V., Viada, C.E., Neninger, E., Rodriguez, P.C., Gonzalez, Z., Gonzalez, A., Crombet, T. |
|---|---|
| Zdroj: | In ESMO Open 30 June-3 July 2018 3 Supplement 2:A420-A420 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|